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Abstract
Most studies on lipid lowering diets have focused on the total content of saturated, polyunsaturated
and monounsaturated fatty acids. However, the distribution of these fatty acids on the
triacylglycerol (TAG) molecule and the molecular TAG species generated by this stereospecificity
are characteristic for various native dietary TAGs. Fat randomization or interesterification is a
process involving the positional redistribution of fatty acids, which leads to the generation of new
TAG molecular species. A comparison between native and randomized TAGs is the subject of this
review with regards to the role of stereospecificity of fatty acids in metabolic processing and effects
on fasting lipids and postprandial lipemia. The positioning of unsaturated versus saturated fatty acids
in the sn-2 position of TAGs indicate differences in early metabolic processing and postprandial
clearance, which may explain modulatory effects on atherogenecity and thrombogenecity. Both
human and animal studies are discussed with implications for human health.
Background
For almost two decades, studies on lipid lowering diets
examined the role of saturated, monounsaturated and
polyunsaturated fatty acids in affecting plasma low den-
sity lipoprotein-cholesterol (LDL-C) concentrations, since
foam cell formation triggered by elevated LDL-C lays the
foundation for atherosclerotic plaques. This landscape
changed in the 1990s, when serum triacylglycerol (TAG)
was identified as an independent cardiovascular risk fac-
tor, and triacylglycerol-rich lipoproteins (TRL) became
implicated in the development of atherosclerosis [1,2].
The progression of coronary atherosclerosis amongst non-
diabetics in the Monitored Atherosclerosis Regression
Study (MARS) was related to TRL levels, whilst angio-
graphic severity of coronary artery disease (CAD) in
another non-diabetic population was reported to be
greater with higher plasma TAG levels [3-5]. In type 2 dia-
betes, angiographic severity of CAD was positively related
to the numbers of circulating TRL particles in plasma, and
this relationship was stronger in women than men, and
independent of high density lipoprotein (HDL) and LDL
[6]. In non-diabetics with moderate hypertriglyceridemia,
about 75% of plasma TAG increase was attributed to the
increased number of TRLs, with small particle sizes (Sf 12
to 60).
The metabolism of TRLs and their effects on remodeling
LDL and HDL during reverse cholesterol transport plays a
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major role in the later stages of atherothrombotic progres-
sion [7]. Elevated TAG, resulting from a fat-rich meal, trig-
gers a chain of metabolic events that reduces HDL-C,
promotes formation of small dense LDL particles, and
activates factor VII (FVII) [8-10]. The size and lipid com-
position of TRL particles in chylomicrons may be involved
in pro-inflammatory atherogenic processes. The induc-
tion of endothelial dysfunction, as well as a prothrombic
state, contributes to cardiovascular dysfunction [11]. The
small size of LDL and its concomitant increased density
and particle number, is also a recognized atherogenic
stimulus. Small dense LDL develops through interactions
with TRLs, particularly large very low density lipoprotein
(VLDL) in the postprandial phase [12].
The prime interest of this review is to examine effects on
lipids and lipoproteins associated with the positional dis-
tribution of dietary fatty acids, esterified to carbon atoms
forming the glycerol backbone of TAG structure. Compar-
isons include both native TAGs and TAGs formulated in a
random or purposeful fashion. Alterations to the TAG
structure are manifested through randomization of native
fats, and the terms "randomization" or "interesterifica-
tion" are used synonymously to designate the process.
Alternately, specific fatty acids can be built into TAG mol-
ecules and such synthetic fats are referred to as "structured
fats". To a large extent TAG structure is important in food
processing since this influences melting characteristics
and crystallization properties of individual fatty acids
making up the TAG molecular species. With the Institute
of Medicine [13] recognition that trans fatty acids arising
from hydrogenation are associated with increased risk for
cardiovascular disease, randomized fats are viewed as a
possible alternate by the food industry to fill the void cre-
ated by the exit of hydrogenated fats.
The metabolic effects of randomized fats, has been
sparsely studied in humans, and literature to date is con-
fined mostly to animal studies [14-16]. Early animal mod-
els of piglets, dogs, rats and hamsters utilized semi
synthetic fats to elucidate the behavior of specific fatty
acids in relation to hypercholesterolemia and the progres-
sion of atherosclerotic lesions [17,18]. In contrast,
increasing citations on the use of structured lipids in cata-
bolically stressed hospital patients is now apparent, but
such literature is not within the scope of this review. Some
recent human postprandial studies [19-22] have probed
TAG structural influences on digestion, absorption and
transport of TAG molecular species rising from C16:0-
rich, C18:1-rich and C18:0-rich fats.
In the subsequent discussion, abbreviations are used to
represent TAG species. For example, POO represents 1-
palmitoyl-2-oleyl-3-oleyl-sn-glycerol and the following
symbols are used to represent the fatty acids discussed in
this review: P = palmitic; O = oleic; S = stearic; D = dodeca-
noic or lauric; C = capric; M = myristic; L = linoleic; Ln =
linolenic; B = butyric.
Stereospecificity of native dietary TAGs
Structure and function
In the native TAG molecule, fatty acids are esterified to
three stereospecific positions on the glycerol backbone.
The positions occupied by these fatty acids are numbered
relative to their stereospecificity or stereospecific number-
ing (sn) as sn-1, sn-2 and sn-3. The orientation of TAG
structure stereospecificity is as follows: if the fatty acid
esterified to the middle carbon of the glycerol backbone is
considered to the left (on the plane of the page), then the
top carbon is numbered sn-1, the bottom carbon is num-
bered sn-3 (below or behind the plane of the page) and
the middle carbon is numbered subsequently as sn-2 [23].
The type of fatty acid and its stereospecificity in TAG
molecular species, largely determines the physical behav-
ior of dietary fats as a whole in food products [24,25].
Quality specifications such as 'mouth feel' in chocolate or
ice-cream, and the 'lightness' of pastry are dependent on
melting point and crystallisation properties of fats. The
melting point of chocolate, just below body temperature,
can be attributed to C18:0 and C16:0 exclusively at sn-1/3
and C18:1 at the sn-2 positions.
Characteristic distribution of TAG species
The stereospecificity of fatty acids in TAGs are characteris-
tic for native oils and fats as indicated in Table 1[26-29].
TAG molecules making up adipose tissue of animals,
largely have a saturated fatty acid (SFA) at the sn-1 posi-
tion and an unsaturated fatty acid at the sn-2 position
[24,27]. For instance, in beef tallow C16:0 is at sn-1 posi-
tion and C18:1 is at sn-2 position as seen in POO, POP
and POS TAGs but vary in the fatty acids located at sn-3.
Contrary to this, in butter fat, C16:0 is not exclusive to sn-
1 but occupies sn-2 in two-thirds of TAG species as seen
for PPB, PPC and PPO TAGs. In lard, C16:0 is located
exclusively at the sn-2 position, with an unsaturated fatty
acid at sn-3 but the fatty acid occupying the sn-1 position
is highly variable, as in SPO, OPL and OPO TAGs [28].
In most vegetables oils, either C18:1 or C18:2 are exclu-
sively at the sn-2 position in TAG species like OOO, LLL,
POL and LLO [24,29]. Linolenic acid (C18:3) occurs less
commonly, but when present, is at the sn-3 position as
seen for OOLn in canola oil. SFAs in vegetable oils such as
palm oil and cocoa butter, occur primarily at the sn-1
position as in POL, POO, POS, SOS, POP and PLL, rarely
at the sn-3 position such as POP, LLP and OOP, but to a
lesser extent at the sn-2 position. Contrary to this trend, in
coconut oil most SFAs ≤ 14 carbon atoms are equitably
distributed in all three stereospecific positions as seen in
DDD, CDD and CDM species (M = myristic; D = dodeca-Nutrition & Metabolism 2007, 4:16 http://www.nutritionandmetabolism.com/content/4/1/16
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noic or lauric acid; C = capric), with C12:0 characteristi-
cally occupying the sn-2 position. Oleic acid is prevalent
in TAG species of animal or plant origin, commonly at the
sn-2 position as observed in olive oil, beef tallow, cocoa
butter, palm oil, peanut oil and canola oil but exclusive to
the sn-1 and sn-3 positions only in lard [24,29].
The difference between bovine and human milk fat lies in
the amount of SFA present in the sn-2 position. In bovine
milk, C16:0 and C18:0 are equitably distributed between
sn-1/3 (34% and 10%) and sn-2 positions (32% and
10%). Human milk has more C16:0 (58%) and less C18:0
(3%) occupying the sn-2 position, in contrast to their
amounts in the sn-1/3 positions (16% and 15% respec-
tively). In addition to various natural dietary fats possess-
ing characteristic TAG molecular species, the presence of
asymmetrical species in vegetable oils has been noted. The
development of advanced techniques for stereospecific
analysis of TAG fatty acids proved the existence of asym-
metry between sn-1 and sn-3 positions [30,31]. Asymmet-
rical fatty acids in these sn-1/3 stereochemical positions
are found in most vegetable oils, and do not exhibit ran-
dom behavior.
Postprandial fate of native dietary TAGs
Hydrolysis in the duodenum
The stereospecificity and chain lengths of fatty acids, at the
sn-1, sn-2 and sn-3 positions in TAG species, determine the
metabolic fate of dietary fat during digestion and absorp-
tion [26,32]. The enzymatic hydrolysis of dietary TAGs is
a major activity of digestion, largely occurring in the duo-
denum. Preferential hydrolysis by pancreatic and lipopro-
tein lipases target the fatty acids in the sn-1 and sn-3
positions resulting in free fatty acids (FFAs) and sn-2
monoacylglycerols [33,34].
It has been suggested, that pancreatic lipase shows greater
affinity for ester bonds in the sn-1 position, compared to
the sn-3 position [35]. Ultimately however, all fatty acids
in the sn-1/3 positions of TAGs are hydrolyzed during
digestion, in contrast to only 22% of fatty acids in the sn-
2 position [36]. Mu and Hoy [37] estimate an approxi-
mate 75% conservation of fatty acids in the sn-2 position,
despite acyl migration to the sn-1/3 positions. They sug-
gest a major factor promoting this conservation is the
regiospecificity of pancreatic lipase for fatty acids in sn-1/
3 positions as well as the chain length of these fatty acids.
Long-chain fatty acids (LCFAs) that contain more than 12
carbons, and short- and medium-chain fatty acids origi-
nating from the sn-1 and sn-3 positions, undergo different
absorption pathways, as will the sn-2 monoacylglycerols
[34]. LCFAs require a protein-mediated process, whilst sn-
2 monoacylglycerols are absorbed by passive diffusion
[38]. In vitro studies with adipocytes suggest the possibil-
ity that fatty acid transport proteins may have different
Table 1: Stereospecificity of dominant TAG molecular species in natural fats and oils
TAG species
Vegetable Oil
Almond oil OOO OLO OLL
Canola oil OOO LOO OOLn
Cocoa butter POS SOS POP
Coconut oil DDD CDD CDM
Corn oil LLL LOL LLP
Cottonseed oil PLL POL LLL
Olive oil OOO OOP OLO
Palm kernel oil DDD MOD ODO
Palm oil POP POO POL
Peanut oil OOL POL OLL
Safflower oil LLL LLO LLP
Soybean oil LLL LLO LLP
Sunflower oil LLL OLL LOO
Walnut oil LLL OLL PLL
Animal Fat
Butter PPB PPC POP
Egg fat POO PLO POS
Lard SPO OPL OPO
Tallow POO POP POS
For fatty acid abbreviations in TAG species read as: P = palmitic; O = oleic; S = stearate; D = dodecanoic or lauric; C = capric; M = myristic; L = 
linoleic; Ln = linolenic; B = butyric.Nutrition & Metabolism 2007, 4:16 http://www.nutritionandmetabolism.com/content/4/1/16
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affinities for different fatty acids, depending on chain
length [39,40].
Changes in chylomicron
Upon entry into the enterocyte, the major site of metabo-
lism of fatty acids will be the endoplasmic reticulum
where TAG structures are reassembled and packaged into
chylomicrons. There is substantial preservation of the
fatty acid at the sn-2 position of the ingested TAG in chy-
lomicrons after digestion [34,41]. Stereospecific structure
of the ingested TAG is also largely preserved in chylomi-
crons [20]. Reassimilation of absorbed sn-2 monoacylg-
lycerides and FFAs occurs via the monoacylglyceride
pathway, or alternately by the α-glycerophosphate path-
way, if the supply of FFAs is more than the monoacylglyc-
erides [42,43]. The sn-2 monoacylglycerols, being
absorbed intact, will serve as a primary backbone for gut
or liver phospholipid synthesis in excessive FFA environ-
ments. Otherwise, sn-2 monoacylglycerols are rapidly
esterified with FFAs into TAGs, which are then incorpo-
rated into lymph chylomicrons.
The metabolic fate of fatty acids released from sn-1 and sn-
3 positions are different from the sn-2 monoacylglycerols.
Fatty acids from the sn-1 and sn-3 positions, with chain
lengths greater than 12 carbon atoms (long chain fatty
acids or LCFAs), are reassembled into new TAG structures
via the phosphatidic acid pathway, which is slower, and
which possibly lowers secretion into the circulation [34].
Additionally, LCFAs have low coefficients of absorption
because their melting points are higher than body temper-
ature, and can form insoluble soaps with calcium. Despite
the regiospecificity for fatty acids in the sn-1/3 positions,
initial low activity of pancreatic lipase towards n-3 fatty
acids specific to the sn-3 position, causes a lag phase in the
supply of sn-2 monoacylglycerols, which eventually
delays formation of TAG in intestinal mucosal cells [37].
Salmon and seal oils, despite sharing a similar FAC, differ
in the stereospecific distribution of sn-3 PUFAs. In salmon
oil the sn-3 FAs are mostly located in the sn-2 position but
in seal oil it is preferentially located at the sn-3 position.
Pancreatic lipase activity towards C20:5n-3 and C22:6n-3
is lower compared to other FAs when located at sn-3 posi-
tion [44]. Ikeda et al. [45], in comparing TAGs containing
C20:5n-3 and C22:6n-3 to triolein, found slower hydrol-
ysis. By using mesenteric lymph collection in rats, lymph
transport following salmon oil was higher in the first 8 h
compared to seal oil, indicating a faster hydrolysis of
salmon oil by pancreatic lipase [46]. However, over 24 h
no difference in accumulated transport was seen between
the oils. Asymmetry may perhaps explain the initial low
activity of pancreatic lipase for LCFA in the sn-3 position
[47,48].
In contrast, fatty acids of short (C4-C6) and medium (C8-
C10) chain fatty acids (SCFAs and MCFAs) solubilize in
intestinal fluids and are absorbed directly into the portal
system. Once in portal circulation the SCFAs and MCFAs
will form complexes with albumin and are carried to the
liver for oxidation.
TAG clearance
The amount of TAGs carried by chylomicrons during the
absorptive stage will vary depending upon the amount of
dietary TAG consumed, and dietary meal constituents.
Following fat absorption, chylomicrons are released into
intestinal lymphatics, enter circulation via the thoracic
duct and move to capillary surfaces of target organs (liver,
heart, etc) or tissue (adipose, skeletal), where TAG disas-
sembly takes place. The norm after a meal is that chylom-
icron breakdown will be directed towards adipose tissue
through the activation of adipose tissue lipoprotein lipase
(LpL). This pathway is triggered by the elevation of
plasma insulin levels which increase concurrent to a meal.
In the fasting state, the hormonal balance favors skeletal
tissues by the activation of muscle LpL. The triple func-
tionality of LpL in relation to processing chylomicrons is
now well-established [49]. Through a process called mar-
gination, LpL first attaches chylomicrons to glu-
cosaminoglycans lining the endothelial wall, lipolyzes the
chylomicron TAGs, and then mediates their binding to
specific lipoprotein receptor protein for liver uptake
[50,51]. LpL exhibits regiospecificity for fatty acids in the
sn-1/3 positions similar to pancreatic lipase [52]. Initially,
susceptibility to LpL hydrolysis of chylomicron TAGS is
said to favor the sn-1 position and results in diacylglycer-
ols comprising sn-2/3 FAs [53,54].
A high LpL activity is associated with a faster chylomicron
TAG clearance, and similarly with low LpL activity, chy-
lomicron clearance will be slowed down [51]. The rate of
hydrolysis is determined by the number of active LpL mol-
ecules in contact with the TAG molecule, as well as the
removal of liberated fatty acids from the capillary micro-
environment. If free fatty acids are not readily removed,
then capillary concentrations will rise rapidly, and LpL
activity will become product inhibited [55]. Prematurely,
chylomicrons and LpL will detach from the endothelial
surface (of adipocytes), leading to the formation of tria-
cylglycerol-rich chylomicron remnants or TRL remnants
[56,57]. The rate of hydrolysis is not determined by LpL
itself, as LpL mass is present normally in excess of need
[58]. Instead the hydrolysis rate is controlled by acylation
stimulating protein (ASP) and insulin, via fatty acid trap-
ping into adipocytes. In healthy humans, half the fatty
acids released from chylomicrons enter adipocytes, and
the other half enters the circulation [59].Nutrition & Metabolism 2007, 4:16 http://www.nutritionandmetabolism.com/content/4/1/16
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The entry of TAGs into the lymphatics via chylomicrons
also provides primary substrates for the 'core pathway' of
the reverse cholesterol transport. The core pathway is the
means by which cholesteryl esters (CE) in HDL are selec-
tively transferred to chylomicrons, in exchange for TAGs,
aided by cholesteryl ester transfer protein (CETP) [60]. As
delipidation continues, there will be changes in density
and size of both HDL and chylomicrons. Chylomicron
particles become progressively smaller as TAG is depleted,
and will be converted into chylomicron remnants [61].
Chylomicron remnant particles carrying CE are removed
by the liver, through the apo E receptor [62-64]. The core
pathway represents the metabolic route for postprandial
lipemia. Chylomicron particles and their remnants are
hypothesized as the major contributors to atherosclerosis,
as excessive postprandial lipemia is associated with
increased risk for myocardial infarction (MI) and stroke
[51].
Altering stereospecificity of fatty acids
Modification of fats
Interesterification is currently viewed as an alternate proc-
ess to the partial hydrogenation of oils and fats. The proc-
ess involves randomization among all three stereospecific
positions, of fatty acids in native edible oils and fats by
either enzymatic or chemical catalysis, at low tempera-
tures. The positional distribution of fatty acids on the glyc-
erol backbone is altered either through fatty acids
switching positions within a TAG molecule, or between
TAGs. If interesterification involves TAG species within
the same dietary fat, the fatty acid composition remains
the same. Sometimes a solid fat is interesterified with liq-
uid oil, and in this case fatty acid composition of the inter-
esterified product will differ.
Randomization allows component fatty acids to be ester-
ified equally [one-third content] to all three glycerol car-
bon atoms (Figure 1), whereas the distribution is specific
and unequal in naturally occurring fats. For example,
McGandy et al. [65] devised semi synthetic fats, in an
attempt to elucidate the specificity of cholesterol-raising
properties of dietary fatty acids. Their fats were developed
by interesterification of naturally occurring fats with tri-
laurin, trimyristin, tripalmitin, and partially hydrogen-
ated soybean oil (providing 85% of C18:0).
Interesterification thus changes the amount of fatty acids
located at the sn-2 position of TAG molecules. A summary
of sn-2 fatty acid comparisons, between some native oils
and fats and their randomized versions, is presented in
Table 2.
Applications of interesterified fats
Randomized fats have diverse applications, both in the
food industry and in clinical applications [15,66]. Interes-
terified fats and oils differ from their native products in
their melting and crystallisation properties and this often
confers desired rhealogical properties to bakery and con-
fectionary products [24,25].
In clinical applications, randomization provides energy-
rich substrates for parenteral, enteral and infant feeding
that are well-absorbed [15,16]. For instance, the optimal
randomization of medium-chain fatty acids in TAG struc-
tures will upon digestion yield sn-1 and sn-3 fatty acids,
which will be absorbed directly into portal circulation
[67]. This application is used in the development of
enteral products benefiting patients with fat malabsorp-
tion disorders [68]. Structured lipid emulsions used in
parenteral feeding of catabolically stressed patients are
said to promote whole body fat oxidation and nitrogen
balance [69-72].
The specific positioning of C16:0 at the sn-2 position in
human milk fat has a biological functionality, as fat
absorption is enhanced [73,74]. Similarly infant formula
products incorporate Betapol™, an interesterified fat with
C16:0 in the sn-2 position, to optimize fat absorption and
minimize calcium excretion [75]. In contrast, poorly
absorbed fats can be designed to benefit weight loss, such
as C18:0 randomized with short-chain fatty acids (C2:0 to
Triacylglycerol molecule structure before and after interest- erification Figure 1
Triacylglycerol molecule structure before and after 
interesterification. An example of a triacylglycerol mole-
cule (POL) that occurs in oils and fats is depicted in which 
palmitic (P), oleic (O) and linoleic (L) fatty acids occupy the 
Sn1, 2 and 3 positions respectively. Following interesterifica-
tion (IE) by either chemical or enzymatic methods, these 
fatty acids are rearranged and take new forms, which would 
include LPO (linoleic-palmitic-oleic), OLP (oleic-linoleic-pal-
mitic) and PLO (palmitic-linoleic-oleic) among the various 
permutations that are possible. Since natural oils and fats are 
made up of a variety of triacylglycerol molecules, interesteri-
fication will result in a large number of new triacylglycerol 
molecules.
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C4:0). An example is the formulation of Salatrim™ or
Caprenin™ containing randomized caprylic, capric and
behenic acids [76-78].
Absorption of interesterified fats
Digestibility of interesterified fats
Early studies on synthetic fats by Kritchevsky [18] in rab-
bits, contributed to the understanding that both TAG
positional isomerism and fatty acid composition of TAG
structure affect fat digestibility. Digestibility falls steeply
with increasing concentrations of tristearin compared to
tripalmitin even at low fat concentration [79]. In rats fed
10% of a target fatty acid or glucose, measuring the coeffi-
cient of fat digestibility in terms of fat excretion, shows
fatty acids 4 to 10 carbon-chain length are absorbed 100%
compared to 86%, 48%, 12% and 84% for C12:0, C16:0,
C18:0 and C18:1 [80].
The ability of fats and fatty acid saturation/unsaturation
to affect uptake during digestion has been examined.
TAGs comprising unsaturated fatty acids are more digesti-
ble compared to free fatty acids for C18:1 (99% vs 73%)
and C18:2 (97% vs 84%) but the reverse is true for C16:0
(22% vs 40%) and C18:0 (14% vs 24%) [81]. Mattson
[82] showed that tristearin (SSS) is totally unabsorbed
compared to almost total absorption of mono- or dis-
tearin-unsaturates, using fat blends or randomized fats
from safflower and hydrogenated linseed oils.
SSS on its own is indigestible, but its digestibility
improves as a mixed glyceride [82,83]. With a total fat
Table 2: Approximate sn-2 fatty acid composition of native vs randomized fats [mol%]
native Randomized
Type of fat Fatty acid Total FAC (%) % mol FA
in sn-2 position
Type of fat % mol FA
in sn-2 position
Cocoa butter [29] 16:0 24 6.8 Salatrim not available
18:0 35 6.8
18:1 36 29.4
18:2 3 3.0
Olive oil [29] 16:0 10 0.3 HOSO [115] 0.1
18:0 2 - 0.1
18:1 76 28.0 92.9
18:2 10 4.7 6.8
Palm oil [29] 16:0 40 4.4 Betapol [120] 72.7
18:0 4 - 6.9
18:1 43 23.1 14.7
18:2 11 6.1 3.6
Peanut oil [110] 16:0 9 0.7 Randomized peanut oil [110] 4.3
18:0 3 tr 1.2
18:1 58 28.5 18.3
18:2 23 12.9 9.6
Cottonseed oil [99] 16:0 24 2.0 Randomized cottonseed oil [99] 8.3
18:0 3 0.2 0.9
18:1 18 7.2 6.0
18:2 53 25.0 17.7
Tallow [105] 16:0 25 3.8 Randomized tallow [105] 8.5
18:0 17 2.2 6.2
18:1 40 19.7 13.1
18:2 3 1.7 0.8
Lard [105] 16:0 21 21.3 Randomized lard [105] 7.6
18:0 11 1.2 3.9
18:1 39 4.9 12.7
18:2 16 2.3 4.7
Fish oil [94] 10:0 - - Randomized fish oil [94] 40.9
14:0 8.5 12.6 5.2
16:0 18 22.3 10.6
18:0 2.1 0.5 1.2
18:1 12.6 7.4 7.3
18:2 2.9 3.0 1.7
20:5 7.6 9.2 4.4
22:6 11.2 21.4 6.5Nutrition & Metabolism 2007, 4:16 http://www.nutritionandmetabolism.com/content/4/1/16
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content of 15%, digestibility was shown in a rat study to
be 39% with tristearin:triolein at 2:1, compared to 69%
for a ratio of 1:2 [83]. Of the predominant TAG molecular
species, 73% of SOO was digested compared to 59% for
SSO, suggesting preferential hydrolysis for C18:1 in the
sn-2 position compared to C18:0. Bergsted et al. [84,85] in
comparing SSS and triolein (OOO) content of lymph,
mucosa and lumen of rats, found 65% less SSS in lymph,
46% less in mucosa, but 660% more in lumen, in contrast
to significantly reduced OOO in the small intestine. The
absorptive index was 94.3% and 56.7% for OOO and SSS
respectively. However, mixing SSS with OOO or tripalmi-
tin (PPP), considerably improved the lymph output in the
order of SSS < SSS+PPP < SSS+OOO.
Influence on dietary cholesterol absorption
Feldman et al. [86] investigated cholesterol absorption in
rats in relation to tristearin, triolein and mixed natural
TAGs from safflower oil. Absorption rates were least with
tristearin (~46%) compared to triolein (~70%) or saf-
flower oil (~75%). Accumulation in lymph was lowest
with tristearin but greatest with sterol synthesis. In
another rat study [87] comparing trilaurin, trimyristin, tri-
palmitin and tristearin, weight gain and cholesterol
absorption was lowest with tristearin, whilst lymph accu-
mulation was in the order of trimyristin (72%) > trilaurin
(58%) > tripalmitin (49%) > tristearin (42%). Imazumi et
al. [88] fed hamsters with high oleic safflower oil
(HOSO), co-randomized with trilaurin, trimyristin, tri-
palmitin or tristearin (yielding 50% targeted SFA with
30% C18:1 and 20% C18:2) with or without 2% choles-
terol. Stearic acid-rich cholesterol-free diets were associ-
ated with the lowest fat digestibility, and greatest steroid
excretion.
Metabolic processing of interesterified fats
Early events in the metabolic processing of synthetic
TAGs, may potentially have a bearing on the development
of risk factors for coronary heart disease (CHD)
[20,34,36,41]. Fundamental to this hypothesis would be
our understanding that enzyme hydrolysis during diges-
tion favors fatty acids in the sn-1/3 positions of TAGs in
contrast to only 22% of fatty acids in the sn-2 position.
Further, there is substantial preservation of the fatty acid
at the sn-2 position of the ingested TAG in chylomicrons
after digestion, and overall stereospecific structure of the
ingested TAG is largely preserved in chylomicrons.
Animal studies
Studies by Innis et al [89,90] lend supportive evidence,
that manipulation of beneficial sn-2 fatty acids in dietary
TAGs, takes into account their conservation during diges-
tion, absorption and reassembly into chylomicron-TAGs.
Newborn piglets were fed sow's milk (55% sn-2 C16:0), or
formulas based on synthesized fats (32% sn-2 C16:0), or
palm olein (4.2% sn-2 C16:0) for 18 days from birth [89].
Measured  sn-2 C16:0 in chylomicron-TAGs, was dose-
dependent to the amount of sn-2 C16:0 in the following
order: sow's milk > synthesized fats > palm olein. In com-
paring formula feeding in piglets, the positional distribu-
tion of C16:0 was the main determinant in weight gain
per liter formula fed, which was greatest with C16:0 in the
sn-2 position [90].
Lower concentrations of C20:4n-6 and C22:6n-3, in chy-
lomicron-TAGs, were associated with synthetic fat feeding
in the piglet study discussed earlier, compared to a for-
mula with palm olein [90]. Positional differences in SFAs
were hypothesized to modulate the transport of n-6 and n-
3 PUFAs [89]. A rat study indicated that dietary fatty acids
in the sn-2 position could influence lipemia and platelet
reactivity, as well as desaturation and elongation of PUFAs
[91]. The sn-2 positions of C18:2, C16:0 and C18:1 were
directly related to plasma levels of C20:4n-6, C16:1n-7
and C20:3n-9 respectively.
Human studies
The natural prevalence of sn-2 16:0 (at 66%) in human
milk fat supports the hypothesis for the enhanced absorp-
tion of sn-2 fatty acids in TAG molecules [73,74]. Altering
the fatty acid at the sn-2 position of diet-TAGs affects the
amount of fat absorbed, as shown in infants fed formula
milk containing randomized lard (sn-1/3 16:0 > sn-2
16:0) versus native lard (sn-1/3 16:0 <sn-2 16:0) [74]. Fat
excretion increased 6-fold for infants fed formula contain-
ing randomized lard, compared to native lard. The associ-
ation of increased fat excretion with sn-1/3 16:0, was also
confirmed in an infant-feeding trial with vegetable oils
providing  sn-2 16:0 at 19% (native) or 44.5% (rand-
omized) [92]. In contrast to infants, adults are hypothe-
sized to have a higher efficiency of absorption irrespective
of positional distribution of fatty acids, but studies sup-
porting this view are inconsistent [66].
According to Summers et al. [20] early metabolic events,
caused by enzymatic-hydrolysis of chylomicron-TAG, are
not influenced by the nature or the position of fatty acids
within dietary TAGs. They found no preferential handling
of either C18:1 or C18:0 randomized at the sn-2 position
in systemic circulation, or in subcutaneous adipose tissue.
TAG hydrolysis in vivo in adipose tissue by lipoprotein
lipase (LpL) was found to be highly efficient, and the com-
position of non-esterified fatty acids released from adi-
pose tissue, matched the composition of diet-TAGs. They
further reported, that there was no release of the fatty acid
from 2-monoacylyglycerol, from either adipose tissue or
chylomicrons, nor were there selective fatty acid uptake or
release from chylomicron TAG, related to the nature or the
sn-2 position of fatty acids. Clearly LpL did not differenti-
ate between sn-2 saturated or sn-2 unsaturated fatty acids.Nutrition & Metabolism 2007, 4:16 http://www.nutritionandmetabolism.com/content/4/1/16
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Symmetry or asymmetry of TAG molecules may make a
difference in early metabolic processing. Sanders et al.
[47,48] found Salatrim™, a randomized C18:0-rich TAG,
or an unrandomized fat such as cocoa butter resulted in
different postprandial effects on lipids and FVII. Symmet-
rical C18:0-rich TAG with C18:1 in the sn-2 position
appeared to be absorbed more rapidly (postprandial
peaking at 4 h) compared to asymmetrical TAG with long
chain-SFAs in the sn-2 position (postprandial peaking at 5
h). Again, asymmetry may perhaps explain the initial low
activity of pancreatic lipase towards n-3 fatty acids specific
to the sn-3 position. This would trigger a lag phase in the
supply of sn-2 monoacylglycerols, which eventually
delays the formation of TAG in intestinal mucosal cells
[37].
Metabolic processing of long chain fatty acids
To overcome the problem of slow hydrolysis of n-3
PUFAs, structured fats have been developed through the
enzymatic interesterification of marine n-3 PUFAs with
MCFAs, on the principle that MCFAs occupying sn-1/3
positions get hydrolyzed earlier than LCFAs in the same
position. Structured oils predominating in MLM species
with decanoic acid (C10:0) mainly in the outer position,
or LML with C20:5n-3 in the sn-1/3 positions, are exam-
ples of oils produced through this process. Rat studies
show hydrolysis rates are 2–3 times faster for MLM-TAGs
compared to LML-TAGs [93]. Alternately, randomized fats
have also been produced through chemical interesterifica-
tion of fish oil with C10:0. A rat study using randomized
fish oil (RFO), MLM, and LML, with native fish oil (FO)
as a control found differences in lymphatic transport [94].
Transport of total TAGs was greater with FO and RFO
compared to the structured oils MLM or LML. Higher
transport of C20:5n-3 in LML and MLM reflected greater
concentrations in the structured oils (for LML 12.2 mol%
and for MLM 34.6%) at sn-2 position compared to either
the FO (9.2 mol%) or RFO (4.4 mol%). Rapid absorption
of C20:5n-3 after MLM, than from LML, was attributed to
faster hydrolysis with C10:0 in the sn-1/3 positions. This
phenomenon has been also observed in thoracic duct-
cannulated rats, showing increased absorption of C18:2n-
6 in the sn-2 position of MLM-type structured TAGs, com-
pared to a trilinolein structured fat [95].
Two oils with equal amounts of C18:1, but differing in
TAG molecular species and minor fatty acid components,
produced different TRL-TAG responses in the postpran-
dial state [21,96]. Major TAG species typical of virgin olive
oil are OOO and POO, whereas OOO is substantially
higher in high oleic acid sunflower oil (HOSO). Meta-
bolic processing of TAG-TRL, despite OOO-rich olive oil
and HOSO diets indicated a decrease in OOO up to 20%
content [21]. The sn-2 fatty acids were largely preserved in
chylomicron-TAGs, but not in VLDL-TAGs in which POO
became the major TAG after feeding C18:1-rich diets [96].
VLDL-TAGs also contained significantly less C18:2, whilst
arachidonic acid increased significantly in the sn-2 posi-
tion, after feeding olive oil compared to HOSO. Olive oil,
in particular, promoted the presence of α-linolenic acid
and docosahexaenoic acid in the sn-2 position of VLDL-
TAGs, possibly through competitive inhibition of arachi-
donic acid utilization by n-3 PUFA [21,96]. OOL, which
was a minor component in both dietary oils, became a
major component in TRL, which is hypothesized to be a
mechanism for supplying tissues with essential C18:2
[21].
Effects of interesterified fats on fasting lipids
A substantial amount of research, evaluating stereospecif-
icity of dietary fats, has focused on C16:0, and to a lesser
extent C18:0, in the need to develop infant milk products
that closely resemble human milk. This led to the conser-
vation of C16:0 at the sn-2 position, and the maxim
"retention and not excretion" for maximizing dietary TAG
absorption. The porcine model is relevant to evaluating
absorption, excretion and lipoprotein parameters, due to
its short growth period (18 days). The rabbit model allows
rapid tracking for atherogenicity. Because of this, there is
paucity of information on the effects of the stereospecific
changes of other SFAs, particularly lauric and myristic, on
lipoprotein and lipid parameters [16].
C16:0 versus C18:1 in the sn-2 position
Palm oil, with C16:0 in the sn-1/3 positions, and
Betapol™, an interesterified fat with C16:0 at the sn-2 posi-
tion were fed to newborn piglets [97]. The sn-2 16:0
resulted in higher TC and HDL-C concentrations com-
pared to C18:1 in the sn-2 position, by the 18th day. This
rise is similar to feeding sow's milk, which has 55% of
C16:0 in the sn-2 position [91].
Newborn piglets developed higher plasma TC and TAG
when fed sow's milk (55% sn-2 C16:0) compared to either
palm olein (4.2% sn-2 C16:0), or synthesized fat (32% sn-
2 C16:0), with or without added cholesterol [90]. TC and
TAG concentrations were similar in the piglets fed either
palm olein or synthesized fat. Obviously, the amount of
C16:0 in the sn-2 position was critical to affecting TC and
TAG levels. Similarly, sn-2 C16:0 in lard elicited higher
plasma TAG values than the sn-1/3 16:0 in palm oil, fed to
rats [92].
A peculiarity reported in rabbit studies, is that interesteri-
fied fats are associated with the development of arthero-
genesis, even without abnormalities in lipid and
lipoprotein metabolism. When native cottonseed oil (2%
sn-2 C16:0) was compared to the randomized version (8
to14%, sn-2 C16:0), atherogenicity increased in rabbits
fed randomized cottonseed oil, without change in TC andNutrition & Metabolism 2007, 4:16 http://www.nutritionandmetabolism.com/content/4/1/16
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TAG concentrations [98,99]. Kritchevsky et al. [100]
hypothesize that enhanced absorption, combined with
prolonged postprandial effects of sn-2 C16:0 brings about
increased exposure of the aorta to C16:0 and subsequent
increased fat deposition. However, these effects could not
be reproduced in the hamster model [16].
In human infants, plasma TAG values were similarly
increased when fed a formula containing randomized
palm oil, with more C16:0 in the sn-2 position [101]. In
contrast, when normocholesterolemic adults were fed
margarine prepared from palm oil (18% sn-2 C16:0 and
82% sn-1/3 C16:0) or palm oil interesterified with sun-
flower oil (65% sn-2 C16:0 and 35% sn-1/3 C16:0), only
men experienced significant increases in TC and LDL-C
concentrations, but not women [23]. Another human
study, also noted positional differences in C16:0 made no
significant difference to blood lipid and lipoprotein levels
[102]. Given these conflicting results, it appears that
human infants and piglets experience raised lipid and
lipoprotein levels in response to sn-2 C16:0, but in adult
humans this effect is not conclusive.
C16:0 versus C18:0 in the sn-2 position
McGandy et al. [65] found C18:0 randomized in synthetic
fat, raised blood cholesterol in human subjects in a simi-
lar manner to C16:0 and C14:0 in native fats. In contrast,
other workers showed either feeding cocoa butter, which
had C18:0 at sn-1/3 positions, or an interesterified fat
blend which had an equitable distribution of C18:0 in all
three positions, did not change blood cholesterol or TAG
levels [103,104].
Native lard (>C18:2 and <C18:0) and native tallow
(<C18:2 and >C18:0) have similar amounts of C16:0
(24%), albeit in different positional distributions (90% of
sn-2 C16:0 for lard compared to 15% for tallow) [105].
Randomization achieves an equitable positional distribu-
tion of the various fatty acids. When such fats were fed to
rabbits, TC was not significantly different between treat-
ments, but the animals developed various degrees of
atherogenicity according to the type of fat fed [105]. The
atherogenic potential of the randomized fats were in the
following order: native lard > randomized lard = rand-
omized tallow > native tallow. In measured terms, the
amount of sn-2 C16:0 as a percentage of total fat in the
four test fats were 21.6%, 8.5%, 7.6% and 3.6% respec-
tively. An inference can be drawn that C18:0, even in the
sn-2 position, was not as atherogenic as C16:0 which
increased atherogenesis in a dose-dependent manner.
C12:0 versus C14:0 versus C16:0 versus C18:0 in the sn-2 position
Normocholesterolemic subjects were fed a blend of com-
mon vegetable oils (coconut, palm oil, palm oil-stearin
and low-trans partially hydrogenated rapeseed oil) or a
randomized version [106]. The fatty acid composition of
both diets was similar, but the positional distribution dif-
fered with more C14:0, C16:0 and C18:0 at the sn-2 posi-
tion in the interesterified fat at the expense of C18:1 and
C12:0. Blood lipids and lipoprotein parameters were not
significantly different between treatments, even when fed
at two different energy levels (4% and 8% of energy).
Corn oil interesterified with trilaurin, trimyristin, tri-
palmitin and tristearin, yielded oils with similar iodine
value but differing in a sn-2 SFA. Kritchevsky and Tepper
[107] fed rabbits with 6% by weight of such structured fats
and 2% cholesterol, compared to native or randomized
corn oil. Fats containing sn-2 SFAs were more atherogenic
than native or randomized corn oil, and C16:0 was the
most atherogenic of the compared sn-2 SFAs. However, TC
levels did not differ between test diets possibly because of
the substantial presence of C18:2. In feeding normocho-
lesterolemic premenopausal women, Snook et al. [108]
kept C18:2 minimal (3% energy) in diets comparing dif-
ferent synthetic fats (trimyristin vs.  tripalmitin  vs.  tris-
tearin at 14% energy). TC, LDL-C and cholesterol ester
concentrations increased the most with C16:0, followed
by C14:0, whilst remaining unchanged with C18:0. Effects
produced by C16:0 and C14:0 were however not statisti-
cally different, which the researchers attributed to subject
phenotype differences causing hyper- and hypo-
responses, specific to either fatty acid.
Long-chain saturated fatty acid (LC-SFA) in the sn-2 position
Long chain-SFAs in native peanut oil are mostly in the sn-
3 position [109]. In primates, randomized peanut oil with
sn-2 LC-SFAs (C20:0-C24:0) induced lesser atherogenicity
than native peanut oil [110]. A rabbit study, comparing
native and randomized peanut oil with corn oil, also
found native peanut oil induced the highest degree of
atherosclerosis, despite unchanged TC levels [111]. The
reduced atherogenicity associated with randomization
was attributed to lower lectin levels by Kritchevsky et al.
[112], which otherwise occur in higher concentrations in
native peanut oil. However, Hayes [15] suggests location
of LC-SFAs at the sn-3 position in native peanut oil could
render the sn-2 PUFA inaccessible, and this plausibly pro-
motes atherogenicity.
A mix of behenic acid (C22:0) at ~45% and capric and
caprylic acids (8:0–10:0) at ~50%, was used in the formu-
lation of Caprenin™. Randomization allows 95% of the
TAG molecules to contain C22:0. In hypercholesterolemic
men fed Caprenin™, after two baseline diets enriched with
palm oil/palm kernel oil or butter, comparisons after six
weeks showed significant reductions in HDL-C, HDL2-C
and HDL3-C [113]. Increase in the TC/HDL-C ratio after
the Caprenin™ diet, without changes in TC, LDL-C, triglyc-
erides, apo B-100 or apo A-1, was noted. Most dietary fatsNutrition & Metabolism 2007, 4:16 http://www.nutritionandmetabolism.com/content/4/1/16
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have C18:1 in a sn-2 position as shown in Table 1. OOO
is the predominant TAG species in olive oil (50%) or high
oleic sunflower oil (HOSO) (65%). In healthy human
subjects, with or without hyperlipidemia, feeding diets
enriched with NCEP Step 1 diet (MUFA = 12% energy), or
MUFA-enriched diets (+10% energy exchanged with car-
bohydrate energy) with either olive oil or HOSO, pro-
duced similar plasma lipid and lipoprotein profiles
[114,115].
Structured fats such as Salatrim™ or Caprenin™, designed
to enable weight loss, have being evaluated for their effect
on blood cholesterol [76-78]. Salatrim™ had no effect on
blood lipids and lipoprotein metabolism, but Caprenin™
was shown to be hypercholesterolemic in men
[113,116,117]. The hypercholesterolemic effect of
Caprenin™ was discussed previously. The different effects
may be possibly attributed to differences in fatty acid
composition, rather than structural differences. Salatrim™
is comprised of C18:0 randomized with short-chain fatty
acids (C2:0 to C4:0), whilst Caprenin™ is formulated with
caprylic, capric (C10:0) and behenic acids (C22:0) [76-
78].
A postprandial study [118] compared butter with fat
replacers (Simplesse™, Olestra™ and Passelli™) and potato
as control, with or without modified sham feeding (MSF).
Simplesse™ is protein-based, whilst Passelli™ is carbohy-
drate-based. Oral exposure by MSF contributed little to
postprandial TAG rise. Fat clearance was slower with but-
ter compared to the fat-replacers. Olestra™ even reduced
the impact of the initial fat challenge below baseline val-
ues. Olestra™ possibly had an impact on lipids stored in
the lacteals or chylomicrons as well as fat absorbed from
oral stimulants [118].
Effects of interesterified fats on the postprandial state
Recognizing the atherogenic potential of TRL, attempts
are underway to define the ideal TAG profile which is least
lipemic postprandially. The traditional long-term feeding
approach, used in most dietary studies, is not optimal for
characterizing fatty acid behavior, with respect to HDL-C,
TAG and TRL generation. The postprandial model, on the
other hand, offers a more valid approach in assessing the
stereospecificity of fatty acids in relation to lipemia. In a
definitive sense, postprandial lipemia represents exoge-
nous lipids drawn from the diet. The degree and magni-
tude of postprandial lipemia, and the nature of TRLs in
chylomicron, are critical to the metabolic processes which
generate TRL remnants and small dense LDL [8]. Studies
using the postprandial lipemic model started since the
1990s, and preferably utilized human subjects, either nor-
mocholesterolemic or with lipoprotein abnormalities.
Information on the influence of dietary TAG structures on
plasma TAG levels, therefore, contributes to an under-
standing of the atherogenic potential of TRL-TAGs.
C16:0-rich fats
Purified LpL from human and animal sources, display
substrate specificity depending on fatty acid and TAG
composition of the diet [53,54]. When fat-enriched chy-
lomicrons or lipid emulsions were injected into rats, both
hydrolysis of TAGs by LpL and liver uptake of remnants
were slower with a SFA in the sn-2 position [119,120].
However, in a postprandial model with human subjects,
Zampelas et al. [121] found TAG clearance, during
lipemia, was not affected by changing the position of die-
tary C16:0 from sn-1/3 positions to the sn-2 position.
Myher et al. [122] found chylomicrons reflected consider-
ably more sn-2 16:0 in humans fed lard, compared to a
control diet with Cl6:0 distributed less at sn-2 and more at
sn-1/3. With piglets, fed palm oil (4% sn-2 16:0) or sow's
milk (55% sn-2 16:0) or formula containing interesteri-
fied palm, sunflower and canola oils (70% sn-2 16:0),
incorporation of C16:0 into plasma TAG and cholesterol
esters 4 h after feeding, was linearly dose-dependent to the
amount of sn-2 16:0 fed [123]. A rat study showed more
C16:0 was absorbed, with increased supply of sn-2 16:0
[124].
In comparing native palm oil and transesterified palm oil
in a human postprandial study, Yli-Jokipii et al. [19,125]
did not find a preferential absorption of sn-2 C16:0. They
differentiated between dietary TAGs, chylomicron-TAGs
and VLDL-TAGs arising from feeding native and rand-
omized palm oil. For chylomicron-TAGs, similarities in
the fatty acid composition between fat loads suggested
C16:0, irrespective of positional distribution, was
absorbed equally. Also, similarities in positional distribu-
tion of chylomicron-TAG and diet-TAG structures indi-
cated the conservation of TAG structures relative to the
test fat loads. In contrast, VLDL-TAG structures were dif-
ferent from the diet-TAGs, with endogenous synthesis as a
possible source. The proportion of TAGs with two C18:1
residues and one C16:0 residue (POO+OOP and OPO),
was reduced significantly in both chylomicrons and VLDL
after both fat loads, and this lower production suggested
endogenous TAG synthesis via glycerol-3-phosphate path-
way. A key difference, arising from change in the posi-
tional distribution of C16:0 reported in their first study
was VLDL-TAG structures were similar for both fat loads,
in all but one regioisomer (POL+LOP and PLO+OLP)
[19]. Additionally, the sn-1/3 16:0 fat caused a larger
incremental area for plasma total TAGs, but reduced
plasma insulin compared to the sn-2 16:0 fat. In the sec-
ond study, Yli-Jokipii et al. [125] reported a slower rate of
chylomicron TAG clearance for transesterified palm oil,
compared to the native palm oil.Nutrition & Metabolism 2007, 4:16 http://www.nutritionandmetabolism.com/content/4/1/16
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C18:1-rich fats
Virgin olive oil (VOO) and HOSO are two oils with equal
amounts of C18:1, but with different compositions of
minor fatty acids and TAG molecular species. VOO has a
higher content of C16:0, C16:1n-7 and C18:3, whereas
HOSO has higher proportions of C18:0 and C18:2. In a
postprandial human study by Abia et al. [21], both oils
elicited equal total TAG plasma concentrations, but their
TAG-TRL responses during the postprandial period were
significantly lowered by VOO, compared to HOSO. C18:1
content did not appear to influence postprandial metabo-
lism, but rather minor fatty acids, C18:0 and C18:2 and
their positional distribution in TAG had physiological rel-
evance. Analysis of 2-monoacylglycerols demonstrated
higher proportions of C18:0 and C16:0 and less C18:1 in
TRL-TAGs derived from HOSO, compared to VOO TAG-
TRL.
C18:0-rich fats
In a series of human postprandial studies, Sanders and co-
workers examined the influence of the TAG structure in a
variety of C18:0-rich fats on postprandial lipemia. A ran-
domized C18:0-rich fat, obtained through the interesteri-
fication of fully hydrogenated with unhydrogenated
sunflower oil (IE-SO), was shown to cause a lesser lipemia
compared to C18:1-rich HOSO oil [47]. This study also
showed reduced activated FVII concentrations with the
randomized C18:0-rich fat, compared to the C18:1-rich
HOSO. Conversely by using cocoa butter with 18:0 pri-
marily in sn-1/3 positions, increased lipemia and acti-
vated FVII similar to the 18:1-rich HOSO, whereas
Salatrim™, a synthetic randomized fat, produced a neutral
effect [48]. Both randomized cocoa butter and IE-SO,
which have more C18:0 in the sn-2 position, produced
lower lipemia and lower activated FVII levels, compared
to unrandomized cocoa butter [126,127].
Another native fat shea butter, despite having a high pro-
portion of C18:0 in the sn-1/3 positions produced a lower
lipemic response compared to C18:1-rich HOSO [128].
Lipemia was unaffected between native and randomized
shea butter [22], while the sn-2 content of dietary TAGs
was maintained in chylomicrons. The lipemic-lowering
effects of randomized C18:0-rich fats were hypothesized
to increase availability of C18:0 in the sn-2 position. Shea
butter's ability in modulating this effect was also attrib-
uted to a lower C16:0 content compared to cocoa butter.
Alternately, randomized C18:0-rich fats having a high
solid content at 37°C, could retard the absorption of fat
[129]. Randomization increases the proportions of trisat-
urated TAG species, which would cause higher melting
points compared to TAG species of increasing unsatura-
tion [26]. However, Shahkhalili et al. [130] found no dif-
ferences in the amount of fat absorbed and excreted, when
testing randomized and unrandomized C18:0 rich fats. A
likely explanation may also lie in the symmetry of dietary
TAG molecules. Asymmetrical TAGs lead to activation of
FVII, which could potentially increase thrombogenic risk
[126]
Variable sn-2 fatty acids
Six interesterified fats were made up to ≈ 43% by weight
by Tholstrup et al [131] with specific target fatty acids at
the sn-2 position. Test fats were produced by interesterifi-
cation of pure TAG (tristearin, tripalmitin, trimyristin)
with high oleic-sunflower oil. Lipemic trends for all test
fats peaked at 4 h. Stearic and palmitic acid rich fats
caused lower lipemias, and slower return to the post-
absorptive state, compared to MUFAs (both cis and trans)
and PUFAs. Fatty acid chain length and degree of satura-
tion influenced the extent and duration of lipemia, and
hepatic VLDL output. LpL activity followed trends similar
to that of lipemia. Cholestryl ester transfer protein (CETP)
activity was not stimulated by most fatty acids during the
prandial events, except for trans  18:1 which induced
greater CETP activity compared to oleic acid after 4 h, A
summary of human studies reviewed in this section is pro-
vided in Table 3.
Metabolic implications on altering stereospecificity of 
TAGs
Zock et al. [23] hypothesize fatty acids in the sn-2 position
are preferentially transported to the liver instead of the
extrahepatic tissues. This was based on the specificity of
LpL in attacking the sn-1/3 positions of the TAG molecule
[33,53]. In the liver, SFAs in the sn-2 position could pref-
erentially affect LDL metabolism compared to the same
SFA at the sn-1/3 positions [132].
Hayes [15] infers that potential benefit or harm to lipo-
protein metabolism from structured fats, might originate
from the consumption of specific TAG species related to
aspects of TAG digestion, absorption and gut TAG resyn-
thesis. The sn-2 monoacylglycerols, which are mostly
PUFA or MUFA in native fats, are absorbed intact and
serve as primary backbones for gut or liver phospholipid
synthesis. Limiting PUFA availability, or insertion of a
dysfunctional fatty acid such as C22:0 or trans 18:1, is
viewed by Hayes [15] as bearing potential harm to lipo-
protein and eicosonoid metabolism. Displacing PUFA or
MUFA from the critical sn-2 position, by substitution with
a SFA or TFA, may directly alter lipoprotein metabolism
through down-regulation of rLDL.
Alternately change in lipoprotein metabolism may be
mediated through the placement of a unique fatty acid in
the  sn-2 position in the phospholipid structure [15].
Changes to phospholipid structure may affect down-
stream metabolic activities involving lecithin:cholesterolNutrition & Metabolism 2007, 4:16 http://www.nutritionandmetabolism.com/content/4/1/16
Page 12 of 17
(page number not for citation purposes)
Table 3: Effects of interesterified fats in the lipemic model
Fat class Reference Study population Study design Diet Endpoints
Palm olein (sn-1/3 
C16:0) vs Betapol™/
interesterified palm 
olein (sn-2 C16:0)
Zampelas et al. [121] 16 healthy men
Mean age: 24.8 ± 2.6 y
Mean BMI: 22.7 ± 2.4 
kg/m2
Randomized cross-
over
2-wk wash-out
6 hr postprandial 
event
Bleeds at -10, 0, 15, 
30, 45, 60, 90, 120, 
180, 240, 300, 360 min
Liquid meal: Meal 
replacement diet 
(Carnation Slender) + 
40 g test fat + 200 ml 
water
Fat clearance: no 
difference
Glucose, insulin and 
GIP: no difference
Palm olein (sn-1/3 
C16:0) vs 
interesterified palm 
olein (sn-2 C16:0)
Yli-Jokipii et al. [19] 11 women
age: 18–45 y
BMI: 18.5–25 kg/m2
Double-blind
Randomized cross-
over
4-wk wash-out
6 hr postprandial 
event
Identical FAC with 
32.8% of 16:0
Positional distribution: 
16:0 in sn-1/3 for PO 
and in sn-2 for 
interesterified PO
Liquid fat load-55 g/m2 
BSA
Fat clearance: no 
difference
IAUC TAG: sn-1/3 
C16:0 > sn-2 C16:0
Insulin: sn-1/3 C16:0 
<sn-2 C16:0
Chylomicron-TAG 
structure: similar to 
diet TAG structure
VLDL-TAG structure: 
similar for both test 
meals but dissimilar to 
diet origin.
Butter vs Fat replacers 
(Paselli™ vs 
Simplesse™ vs 
Olestra™)
Mattes [118] 2 men and 15 women
Age: 28.5 ± 1.9 y 
BMI:26.1 ± 1.4 kg/m2
Randomized 
crossover
80 g almond evening 
meal prior to 
postprandial day
Modified sham feeding 
(MSF) for oral 
stimulation
0 h: baseline bleed
+10 min: 50 g 
safflower oil capsule
+ 20 min: blood 
drawn
+ every 3 min for 60 
min: MSF
+ every 15 min for 60 
min: MSF
+ bleeds at 2.5 h, 4.5 
h, 6.5 h, 8.5 h after 
baseline
MSF @ 2 hr after 
baseline.
Mashed potato alone 
as control.
Test fat (= 50 g) fed in 
capsules with mashed 
potato.
AUC TAG: Butter > 
potato = Paselli™ = 
No MSF > 
Simplesse™ > Olestra
Serum 18:1, apo B48, 
apo B 100: no 
treatment effects
Interesterified C18:0-
rich sunflower oil vs 
C18:1-rich HOSO
Sanders et al. [47] 16 healthy subjects: 11 
men, 5 women
mean age (yr): 25.5
mean BMI (kg/m2): 
23.2
Randomized 
crossover
7 hr postprandial 
events
0,1,2,4 and 5 hr drawn 
capillary blood
3 and 7 hr venous 
blood
Test fat : 90 g vs Low 
fat = 10 g
Test meal challenge: 
cottage pie + banana 
milkshake with
total nutrient value of 
5.2 MJ, 37 g protein
Fat-free lunch (1.7 MJ) 
after 3 hr
FVIIa: sn-2 C18:1 > sn-
2 C18:0
Plasma TAG: sn-2 
C18:1 > sn-2 C18:0
C18:0-rich cocoa 
butter (sn-1/3 C18:0) 
vs C18:1-rich HOSO 
(sn-2 C18:1) vs 
randomized C18:0-
rich Salatrim™ (sn-2 
C18:0)
Sanders et al. [48] 17 men and 18 
women
mean age (yr): men 
51.3; women 46.2
mean BMI (kg/m2): 
men 25.9 and women 
26.5
Randomized 
crossover
3 wk feeding per 
phase
with 1 wk wash-out
0, 3 and 6 hr 
postprandial events
Test fat:30 g
Test meal: muffin + 
strawberry milkshake
Total nutrient value: 
50 g fat, 17 g protein, 
48 g carbohydrate
FVIIa: sn-1/3 C18:0 = 
sn-2 C18:1 > sn-2 
C18:0
Plasma TAG: sn-1/3 
C18:0 = sn-2 C18:1> 
sn-2 C18:0Nutrition & Metabolism 2007, 4:16 http://www.nutritionandmetabolism.com/content/4/1/16
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acyltransferase (LCAT) activity in the circulation. Unester-
ified cholesterol within circulating plasma lipoproteins is
esterified to form cholesteryl esters (CE) by LCAT, which
will then be transferred to HDL during reverse cholesterol
transport. Further, acyl coenzyme A: cholesterol acyltrans-
ferase (ACAT) activity in the liver will promote the esteri-
fication of FC, shifting the equilibrium in favor of the CE
pool, which leads to the 'up-regulation' of rLDL and
reduced LDL-C levels [133]. Additionally, potential bene-
fits or harm may be mediated through eicosonoid metab-
olism, such as the release of sn-2 fatty acids from
phospholipids by phospholipase A2, or the generation of
specific diacylglycerol from membrane phosphatidyl
inositol by phospholipase C.
Summary
Stereospecificity of most native oils and fats favor PUFA or
MUFA in the sn-2 position, whilst SFAs are mainly distrib-
uted at the sn-1/3 positions. Interesterification has the
capacity to invert this distribution by placing saturated
fatty acids in the sn-2 position. Stereospecific structure
and the sn-2 fatty acid position of the ingested TAG, are
substantially preserved in chylomicrons. However, dietary
TAG structure may not be conserved in VLDL-TAGs, as
seen by the increase of POO after feeding C18:1-rich diets.
Early metabolic events caused by LpL-hydrolysis of chy-
lomicron-TAG are not influenced by the nature or the
position of fatty acids within dietary TAG. Clearly LpL
does not differentiate between sn-2 saturated or sn-2
unsaturated fatty acids. However, symmetry or asymmetry
of TAG molecules may possibly make a difference in early
metabolic processing, as symmetrical TAG molecules with
C18:1 occupying the sn-2 position promotes a more rapid
postprandial clearance from circulation.
Displacing PUFA or MUFA from the critical sn-2 position,
by substitution with SFA, is hypothesized to cause lipid
and lipoprotein abnormalities. Studies comparing the
chain length of SFAs are limited, but indicate that satu-
rates are most detrimental in the sn-2 position. For exam-
ple, the amount of C16:0 in the sn-2 position influences
TC and TAG levels in piglets and human infants. How-
C18:0 rich cocoa 
butter (sn-1/3 C18:0) 
vs
interesterified cocoa 
butter (sn-2 C18:0)
Sanders et al. [126] 17 healthy males
mean age: 38.2 yr
mean BMI: 24.5 kg/m2
Randomized 
crossover
3 wk feeding per 
phase
≥ 1 wk wash-out
1,2,4 and 5 h 
postprandial events
Test meal: milkshake 
+ muffin
Nutrient value: 3.13 
MJ, 16 g protein+ 50 g 
carbohydrate + 50 g 
test fat
3 h post-meal: fruit 
and low-fat yoghurt
FVIIa: sn-1/3 C18:0 
<sn-2 C18:0
Plasma TAG: sn-1/3 
C18:0 > sn-2 C18:0
C18:0 rich cocoa 
butter (sn-1/3 C18:0) 
vs
Interesterified C18:0-
rich sunflower oil (sn-
2 C18:0)
Berry & Sanders [128] 6 healthy males
age: 20–40 yr
Randomized 
crossover
6 hr postprandial 
event
Test fat: 50 g FVIIa: sn-1/3 C18:0 
<sn-2 C18:0
Plasma TAG: sn-1/3 
C18:0 > sn-2 C18:0
Unrandomized shea 
butter (sn-1/3 C18:0) 
vs randomized shea 
butter (sn-2 C18:0)
Berry & Sanders [22] 16 healthy males Randomized 
crossover trial
Test fat: 50 g
Test meal: muffins
FVIIa: sn-1/3 C18:0 = 
sn-2 C18:0
Plasma TAG: sn-1/3 
C18:0 = sn-2 C18:0
Unrandomized shea 
butter (sn-1/3 C18:0) 
vs C18:1-rich HOSO 
(sn-2 C18:1)
Berry & Sanders [129] 13 healthy males
age: 20–43 yr
Randomized 
crossover trial
6 hr postprandial 
event
Test fat: 50 g FVIIa: sn-2 C18:1 > sn-
1/3 C18:0
Plasma TAG: sn-2 
C18:1 > sn-1/3 C18:0
Interesterified fatty 
acids
sn-2 C18:0 (n = 16)
sn-2 C16:0 (n = 16)
sn-2 C18:2 (n = 16)
sn-2 C18:1 (n = 16)
sn-2 C14:0+C16:0 (n 
= 8)
sn-2 trans C18:1(n = 
15)
Tholstrup et al. [131] 16 healthy men
age: 21 to 28 yr
BMI: 19.5 to 28.1 kg/
m2
Crossover design
≥ 3 wk wash-out
2 days familiarization
Total fat energy-50.6%
SFA:PUFA:MUFA = 
40:41:19
Interesterified fatty 
acids targeted at ≈ 
43% by wt
Single meal fat-
loading:1 g/kg BW
Fat clearance: C18:0 = 
C16:0 < C16:0+C14:0 
<cis and trans C18:1 < 
C18:2
LpL: C18:0 = C16:0 = 
C16:0+C14:0 <cis 
C18:1 <trans C18:1 < 
C18:2
CETP: ↑ for trans 
C18:1 after 4 h; ↓ for 
C18:0 and C18:2 until 
4 h; no change for the 
rest.
Table 3: Effects of interesterified fats in the lipemic model (Continued)Nutrition & Metabolism 2007, 4:16 http://www.nutritionandmetabolism.com/content/4/1/16
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ever, this effect has not been clearly demonstrated in
human studies. In the rabbit model sn-2 16:0 appears to
contribute to the development of atherogenicity in a dose-
dependent manner, but other animal models do not show
this effect. Overall, it is still too early to conclude on the
behavior of unusual positional distribution of fatty acids
in TAG species originating from dietary fats and oils. More
studies that reflect postprandial events will elucidate the
type of TAG molecular species in TAG-rich lipoproteins,
that are either directly atherogenic, or influence the devel-
opment of small and dense LDL particles.
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